Exploring Three Undiscovered Gems In The United States Market

The market is up 1.0% over the last week and has seen a remarkable 28% increase over the past 12 months, with earnings expected to grow by 15% per annum in the coming years. In this robust environment, identifying undiscovered gems can provide significant opportunities for investors looking to capitalize on emerging growth potential.

Top 10 Undiscovered Gems With Strong Fundamentals In The United States

Name	Debt To Equity	Revenue Growth	Earnings Growth	Health Rating
Morris State Bancshares	10.20%	-0.28%	6.97%	★★★★★★
Teekay	NA	-6.48%	55.79%	★★★★★★
Mission Bancorp	25.37%	16.23%	20.16%	★★★★★★
Omega Flex	NA	1.31%	3.88%	★★★★★★
First Northern Community Bancorp	NA	7.12%	10.04%	★★★★★★
Banco Latinoamericano de Comercio Exterior S. A	311.64%	21.07%	24.77%	★★★★★☆
Innovex International	19.92%	29.88%	40.68%	★★★★★☆
San Juan Basin Royalty Trust	NA	33.61%	35.00%	★★★★★☆
Valhi	38.71%	2.57%	-19.76%	★★★★★☆
FRMO	0.17%	12.99%	23.62%	★★★★☆☆

Click here to see the full list of 209 stocks from our US Undiscovered Gems With Strong Fundamentals screener.

Let's dive into some prime choices out of from the screener.

Viemed Healthcare (NasdaqCM:VMD)

Simply Wall St Value Rating: ★★★★★★

Overview: Viemed Healthcare, Inc., along with its subsidiaries, offers home medical equipment and post-acute respiratory healthcare services to patients in the United States and has a market cap of $295.08 million.

Operations: Viemed Healthcare generates revenue primarily from its Sleep and Respiratory Disorders Sector, amounting to $205.70 million.

Viemed Healthcare has shown robust performance with earnings growing 29% last year, outpacing the healthcare industry’s 6%. The company boasts a satisfactory net debt to equity ratio of 0.6%, and its interest payments are well covered by EBIT at 19x. Despite a dip in Q2 net income to US$1.47 million from US$2.33 million, revenue guidance for Q3 is promising at around US$56.5-57.7 million, indicating potential continued growth.

• Navigate through the intricacies of Viemed Healthcare with our comprehensive health report here.

• Gain insights into Viemed Healthcare's historical performance by reviewing our past performance report.

Gatos Silver (NYSE:GATO)

Simply Wall St Value Rating: ★★★★★★

Overview: Gatos Silver, Inc. is involved in the exploration, development, and production of precious metals with a market cap of $1.06 billion (NYSE:GATO).

Operations: Gatos Silver, Inc. generates its revenue primarily from the exploration, development, and production of precious metals. The company has a market cap of $1.06 billion (NYSE:GATO).

Gatos Silver has seen impressive earnings growth of 397.4% over the past year, outpacing the Metals and Mining industry’s -23%. The company is debt-free and reported net income of US$9.16 million for Q2 2024, a significant improvement from a net loss of US$3.59 million a year ago. Recently, First Majestic Silver Corp announced plans to acquire Gatos for approximately US$950 million, valuing each Gatos share at $13.49 based on current prices.

• Click here and access our complete health analysis report to understand the dynamics of Gatos Silver.

• Review our historical performance report to gain insights into Gatos Silver's's past performance.

Innovex International (NYSE:INVX)

Simply Wall St Value Rating: ★★★★★☆

Overview: Innovex International, Inc. designs, manufactures, installs, rents, and sells a suite of well-centric engineered products to oil and gas industries worldwide with a market cap of $1.07 billion.

Operations: Innovex International generates revenue primarily from its oil well equipment and services segment, amounting to $550.34 million. The company's market cap stands at $1.07 billion.

Innovex International, a small player in the energy services sector, has shown impressive earnings growth of 40.7% over the past year, outpacing the industry average of 12.9%. Their debt situation appears manageable with an interest coverage ratio of 14.8x EBIT and a net debt to equity ratio at 14.3%. Despite trading at nearly 95% below its estimated fair value, recent financials indicate some challenges; for instance, second-quarter sales dropped to US$130.3 million from US$147.64 million last year while net income fell to US$9.53 million from US$20.59 million during the same period.

• Click here to discover the nuances of Innovex International with our detailed analytical health report.

• Learn about Innovex International's historical performance.

Next Steps

• Click through to start exploring the rest of the 206 US Undiscovered Gems With Strong Fundamentals now.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com